BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38128397)

  • 1. Corynoline inhibits esophageal squamous cell carcinoma growth via targeting Pim-3.
    Shi Y; Yuan Q; Chen Y; Li X; Zhou Y; Zhou H; Peng F; Jiang Y; Qiao Y; Zhao J; Zhang C; Wang J; Liu K; Dong Z
    Phytomedicine; 2024 Jan; 123():155235. PubMed ID: 38128397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.
    Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L
    Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
    Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
    Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
    Qiu F; Liu L; Lin Y; Yang Z; Qiu F
    Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
    Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
    Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Song M; Qu Y; Jia H; Zhang Y; Liu S; Laster KV; Choi BY; Tian J; Gu T; Chen H; Liu K; Lee MH; Dong Z
    Mol Carcinog; 2024 May; 63(5):991-1008. PubMed ID: 38376345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway.
    Duan X; Chen Y; Zhang K; Chen W; Zhao J; Dai X; Cao W; Dong Z; Mo S; Lu J
    Cell Signal; 2023 Sep; 109():110736. PubMed ID: 37263462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK1 contributes to cisplatin-induced apoptosis of esophageal squamous cell carcinoma cells via activation of JNK pathway.
    Zhang Y; Du J; Duan X; Peng W; Lv L; Chen Z; Zhang Y
    Life Sci; 2021 Mar; 269():119064. PubMed ID: 33460665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis.
    Ma L; Li H; Lin Y; Wang G; Xu Q; Chen Y; Xiao K; Rao X
    J Surg Res; 2021 Apr; 260():64-75. PubMed ID: 33326930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OP16 induces deadly autophagy and apoptosis of cells by inhibiting Akt in esophageal squamous cell carcinoma.
    Hou G; Jia A; Yang L; Zhao Y; Hu Y; Zhao W; Zhao W; Liu HM; Lu Z
    Mol Cell Biochem; 2020 Sep; 472(1-2):219-230. PubMed ID: 32671513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation.
    Li S; Xi Y; Zhang H; Wang Y; Wang X; Liu H; Chen K
    Oncol Rep; 2010 Oct; 24(4):997-1004. PubMed ID: 20811681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.
    Jia X; Wang P; Huang C; Zhao D; Wu Q; Lu B; Nie W; Huang L; Tian X; Li P; Laster KV; Jiang Y; Li X; Li H; Dong Z; Liu K
    J Exp Clin Cancer Res; 2023 Apr; 42(1):97. PubMed ID: 37088855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.